Top Markets
#1 Fake World Assets Fake World Assets +11.59%
#2 TENDIES TENDIES +4.80%
#3 GoPlus Security GoPlus Security +4.67%
#4 Everything Everything +3.70%
#5 TronBank TronBank +3.67%
#6 Janction Janction +3.26%
#7 Prom Prom +3.26%
#8 Tutorial Tutorial +3.00%
#9 DUSK Network DUSK Network +2.91%
#10 Humanity Humanity +2.36%
Coin of the day
Fake World Assets Fake World Assets
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Ultimovacs ASA Ultimovacs ASA

Ultimovacs ASA

ULTI
Clasificación en acciones #34179
Ultimovacs ASA is a pharmaceutical company based in Oslo, Norway, established... Ultimovacs ASA is a pharmaceutical company based in Oslo, Norway, established in 2011. The firm specializes in developing immunotherapies to combat various cancers. Its main product in development is UV1, a peptide vaccine engineered to stimulate a T-cell immune response against telomerase, an antigen found widely across different cancer types.
Precio por acción
$0.17687105
Última sincronización: 2025-04-01
Capitalización bursátil
$6.08M
Cambio (1 día)
-89.96%
Cambio (1 año)
0.00%
País
NO
Comercio Ultimovacs ASA (ULTI)

Categoría

Healthcare
Ratio P/S de Ultimovacs ASA (ULTI)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Ultimovacs ASA, el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Ultimovacs ASA desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE